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Abstract: Recent studies have indicated that distal radial access (DRA) is feasible in patients undergoing
percutaneous coronary intervention (PCI). The present study aimed to compare DRA, proximal radial
access (PRA), and femoral access (FA) in patients with ST-elevation myocardial infarction (STEMI)
undergoing PCI. Data were analyzed for 109 patients with STEMI treated via primary PCI from
March 2020 to May 2021. The success rate of DRA was 83.3% (35/42), including seven cases of failed
puncture (puncture failure = 5, severe radial artery spasm = 2). Primary PCI via the DRA was successful
in all 35 patients. After classifying the patients requiring crossover into a separate group, the percentage
of the puncture time in the door-to-wiring time was 2.7% [2.2–4.3], 3.3% [2.3–4.0], 2.6% [1.2–4.9], and
27.0% [13.5–29.3] in the DRA (n = 35), PRA (n = 24), FA (n = 26), and crossover (n = 9) groups, respectively
(p < 0.01). Only two local hematomas (≤5 cm) occurred in the DRA group, while one patient in the FA
group required surgical treatment and a transfusion for an access-site vascular injury. When performed
by an experienced operator, DRA may represent a feasible alternative to other access routes in select
patients with STEMI undergoing PCI, such as those with a high risk of bleeding.
Keywords: radial artery; ST-elevation myocardial infarction; percutaneous coronary interven-
tion; bleeding
1. Introduction
Proximal radial access (PRA) for cardiac catheterization is associated with a better
ability to achieve hemostasis, greater patient comfort, earlier ambulation, and shorter
duration of hospitalization than femoral access (FA) [1]. Moreover, recent randomized
trials and meta-analyses have demonstrated that PRA is associated with a reduced risk of
access-site complications, major bleeding, and mortality in patients with acute coronary
syndrome, when compared to FA [2–5]. Accordingly, current guidelines recommended
PRA as the standard approach for percutaneous coronary intervention (PCI). In addition,
for experienced radial operators, PRA is recommended over FA when performing primary
PCI in patients with ST-elevation myocardial infarction (STEMI) [6,7].
Previous studies have demonstrated that the recently introduced strategy of distal
radial access (DRA) is feasible and exhibits several advantages over PRA, including reduc-
tions in the risk of puncture-related injuries to the proximal radial artery and access-site
complications such as significant bleeding [8–12]. More recently, a randomized trial demon-
strated rates of radial artery occlusion are lower following DRA than following PRA [13].
From this perspective, DRA may represent an alternative access route for primary PCI
in select patients with STEMI taking potent P2Y12 inhibitors (e.g., ticagrelor or prasugrel)
or glycoprotein IIb/IIIa inhibitors [14]. However, there is a paucity of data regarding the
comparison among vascular access routes in the setting of STEMI. Therefore, the present
J. Clin. Med. 2021, 10, 3438. https://doi.org/10.3390/jcm10153438 https://www.mdpi.com/journal/jcm
J. Clin. Med. 2021, 10, 3438 2 of 9
study aimed to compare the safety and feasibility of DRA, PRA, and FA in patients with
STEMI undergoing PCI.
2. Materials and Methods
2.1. Patients and Study Design
From March 2020 to May 2021, patients who underwent primary PCI for STEMI at
Yongin Severance Hospital were enrolled in the current study. A total of five experienced
radial operators, defined as operators who perform at least 50% of all PCI procedures
in patients with acute coronary syndrome via the radial approach, participated in this
study [15]. Of these five operators, two were experienced DRA operators, and the other
three had never utilized DRA at the beginning of patient registration in March 2020. The
study protocol was approved by the Institutional Review Board of Yongin Severance
Hospital (approval number: 9-2021-0069), which waived the requirement for informed
consent owing to the retrospective observational study design.
2.2. Preparation for Each Vascular Access Route
Detailed information regarding DRA has been described previous studies of PCI via the
DRA [12]. After procedure, hemostasis was achieved with a compressive bandage with gauze
for 3 h in DRA [16]. During PRA, the arm was positioned by the side of the body on an arm
board. For easier puncture, a soft roll was placed under the wrist to ensure hyperextension
of the wrist. For left PRA, the hand was positioned over the left groin with a soft cushion
kept under the left elbow, and the same positioning was used for left DRA. Following the PCI
procedure, the radial sheath was removed, and a compression bandage was applied for 4 h.
In the case of FA, ultrasound-guided puncture was performed in all patients to reduce the
risk of access-site complications. After the procedure, the decision to use a vascular closure
device (VCD), as well as the type of VCD, was left to the operator’s discretion.
2.3. Primary PCI Procedures
Immediately after the diagnosis of STEMI, all patients were given a loading dose
of aspirin (300 mg), a P2Y12 receptor inhibitor (180 mg of ticagrelor or 300–600 mg of
clopidogrel), and 5000 units of unfractionated heparin before the procedure if they were
not previously taking these medications. The choice of medication was determined by
each physician. Primary PCI was performed in accordance with the standard technique
and current guidelines for STEMI [6]. Additional unfractionated heparin (50 to 70 U/kg)
was administered during the procedure to maintain the activated clotting time at 250 to
300 s. Details regarding the treatment strategy including the sheath size, use of thrombus
aspiration, use of glycoprotein IIb/IIIa inhibitors, intravascular imaging guidance, and the
need for stent implantation were determined according to the physician’s discretion.
2.4. Definitions and Study Endpoints
STEMI was defined as new ST-segment elevation >0.1 mV in at least two contiguous
leads and a new left bundle branch block on 12-lead electrocardiogram with a concomi-
tant increase in cardiac markers (creatinine kinase-myocardial band [MB] or troponin T).
Primary PCI was defined as PCI in patients presenting within 12 h of symptom onset or
>12 h from symptom onset with clinical and/or electrocardiographic evidence of ongoing
ischemia [6]. Successful vascular access was defined as the success of sheath cannulation.
Puncture time was defined as the time interval from local anesthesia induction to successful
sheath cannulation. Door-to-wiring-time (D2WT) was defined as the time elapsed from
arrival of the patient at the emergency department to guide wire passage through the
lesion. Major bleeding was defined as Bleeding Academic Research Consortium (BARC)
type 3 or 5 bleeding [17].
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The primary endpoint was the rate of access-site complications including major bleed-
ing requiring transfusion or surgery, hematoma, and arterial occlusion. Secondary end-
points included the puncture success rate, success rate of primary PCI, and the percentage
of puncture time in D2WT.
2.5. Statistical Analysis
Normally distributed continuous variables are expressed as means ± standard deviations
(SD), while non-normally distributed continuous variables are expressed as medians and
interquartile ranges (IQR). All categorical variables are presented as numbers with percentile
values. Continuous variables were compared using one-way analyses of variance (ANOVAs),
Kruskal-Wallis tests, Student’s t-tests, or Mann-Whitney U-tests, as indicated. Categorical
variables were compared using chi-square tests. A two-sided p value of less than 0.05
was considered statistically significant. All statistical analyses were performed using SPSS
statistical software (SPSS version 25.0 for Windows; IBM Corp., Armonk, NY, USA).
3. Results
From March 2020 to May 2021, we identified 109 consecutive patients who underwent
primary PCI for STEMI. Among them, 13 patients with refractory cardiogenic shock
requiring extracorporeal membrane oxygenation were excluded, and a total of 97 patients
were enrolled. DRA, PRA, and FA were firstly attempted in 42, 26, and 26 patients during
the study period, respectively (Figure 1). The success rate of DRA was 83.3% (35/42).
Among the seven cases of failed DRA, distal radial artery puncture failed in five patients,
while sheath cannulation failed after successful puncture in two cases due to severe arterial
spasms accompanied by pain. Crossover to PRA and FA was achieved in one and six
patients, respectively. However, the success rate of primary PCI was 100% in all 35 patients
in whom successful DRA was achieved (Table 1). Vascular access was ultimately successful
in all cases of PRA when including crossover cases (initial PRA = 26, crossover from DRA
to PRA = 1). However, due to subclavian tortuosity and anomalous origin of the right
coronary artery (RCA), subsequent crossover to FA was required in two patients. Finally, 35,
25, and 34 patients were enrolled in the DRA, PRA, and FA groups for analysis, respectively.
Figure 1. Study flowchart. Abbreviations: ECMO, extracorporeal membrane oxygenation; DRA, distal radial access;
FA, femoral access; PCI, percutaneous coronary intervention; PRA, proximal radial access; RCA, right coronary artery;
STEMI, ST-elevation myocardial infarction.
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Table 1. Detailed information regarding vascular access routes.
Characteristics DRA PRA FA
Attempted puncture (number of patients) 42 27 34
Puncture success rate 35 (83.3) 27 (100) 34 (100)
Crossover to other access site 7 2 0
Proximal radial access 1 (14.3) 0 0
Femoral access 6 (85.7) 2 (100) 0
Patients with successful access 35 27 34
Left-sided access 34 (97.1) 11 (40.7) 2 (7.7)
Success rate of diagnostic CAG 35 (100) 25 (92.6) 34 (100)
Success rate of primary PCI 35 (100) 25 (92.6) 34 (100)
Data are presented as number (%). Abbreviations: DRA, distal radial access; PRA, proximal radial access; FA,
femoral access; CAG, coronary angiography; PCI, percutaneous coronary intervention.
Baseline characteristics of the study population are presented in Supplementary
Table S1. The overall average age of the patients was 60.4 ± 13.3 years (range: 29–88 years),
and 86.2% (81/94) were male. The baseline characteristics did not significantly differ
among the three groups, except that the hemoglobin level was lower in the FA group than
in the other two groups.
Angiographic and procedural characteristics are listed in Supplementary Table S2.
Temporary pacemaker implantation was performed more frequently in the FA group than
in the DRA and PRA groups (p < 0.01). Total procedure time and contrast volume were
comparable among the three groups. Primary PCI with a 6-French guiding catheter was
performed in 77.1%, 100%, and 85.3% of patients in the DRA, PRA, and FA groups, respec-
tively. Infarct-related artery, disease extent, total number of implanted stents, multivessel
PCI, intravascular imaging-guided PCI, and the use of thrombus aspiration and glycopro-
tein IIb/IIIa inhibitors were comparable among the three groups. In the FA group, VCD
was used in 91.2% (31/34) of patients.
After classifying patients requiring crossover of vascular access separately, mean
puncture times in the DRA, RA, FA, and crossover groups were 116 ± 56, 101 ± 46,
129 ± 106, and 1033 ± 693 s, respectively (p = 0.03). To determine the safety of puncture
for primary PCI, we also evaluated the percentage of puncture time in the D2WT, which
was 2.7% [2.2–4.3], 3.3% [2.3–4.0], 2.6% [1.2–4.9], and 27.0% [13.5–29.3] in the DRA, RA, FA,
and crossover groups, respectively (p < 0.01) (Table 2 and Figure 2).
Table 2. Detailed information regarding vascular access routes after separating crossover cases.






(n = 9) p Value
Puncture time, s <0.01 †
Mean ± standard deviation 116.1 ± 56.1 100.8 ± 46.0 129.2 ± 105.9 1033.3 ± 692.5
Median (IQR) 91 (78–150) 87 (61–120) 120 (53–195) 960 (390–1380)
Puncture time <3 min 31 (88.6) 22 (91.7) 20 (76.9) 0 <0.01
Puncture time <5 min 35 (100) 24 (100) 25 (96.2) 1 (11.1) <0.01
Door-to-wiring time (D2WT), min 62.7 ± 28.5 59.2 ± 37.8 80.1 ± 51.8 69.4 ± 34.5 0.17
Proportion of puncture time to
D2WT, % 3.5 ± 2.0 3.4 ± 1.8 3.4 ± 2.7 23.1 ± 8.2 <0.01
§
Data are presented as mean ± SD, number (%), or median (quartile 1–quartile 3). † p value for DRA vs. PRA, 0.27; DRA vs. FA, 0.54; PRA
vs. FA, 0.23; DRA vs. crossover, <0.01; PRA vs. crossover, <0.01, FA vs. crossover, <0.01. § p value for DRA vs. PRA, 0.84; DRA vs. FA, 0.89;
PRA vs. FA, 0.98; DRA vs. crossover, <0.01, PRA vs. crossover, <0.01, FA vs. crossover, <0.01. Abbreviations: IQR, interquartile range; DRA,
distal radial access; PRA, proximal radial access; FA, femoral access.
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Figure 2. Percentage of the puncture time in the door-to-wiring time. Horizontal lines represent the
median with the interquartile range. Abbreviations: DRA, distal radial access; FA, femoral access;
PRA, proximal radial access.
Access-site complications are summarized in Table 3. Local hematoma less than 5 cm
in diameter occurred in two (5.7%) patients in the DRA group, two (8.0%) patients in
the PRA group, and four (11.8%) patients in the FA group (p = 0.66). One patient who
underwent primary PCI via FA underwent subsequent surgery and a blood transfusion for
damage to the femoral artery and vein during vascular access.
Table 3. Outcomes.




(n = 34) p Value
Access-site complications 2 (5.7) 2 (8.0) 4 (11.8) 0.66
Local hematoma (≤5 cm) 2 (5.7) 2 (8.0) 4 (11.8) 0.66
Local hematoma (>5 cm) 0 0 0 -
Bleeding requiring
transfusion or surgery 0 0 1 (2.9) 0.41
Puncture site injury 0 0 1 (2.9) 0.41
Pseudoaneurysm 0 0 0 -
Arteriovenous fistula 0 0 0 -
Occlusion 0 0 0 -
Hemorrhagic stroke 0 0 0 -
Myocardial infarction 0 0 0 -
BARC bleeding 0 0 1 (2.9)
Type 3a 0 0 0
0.41Type 3b 0 0 1 (2.9)
Type 5 0 0 0
Data are presented as mean ± SD or number (%). Abbreviation: DRA, distal radial access; PRA, proximal radial
access; FA, femoral access; BARC, Bleeding Academic Research Consortium.
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4. Discussion
To the best of our knowledge, this is the first clinical study to compare the safety and
feasibility of DRA, PRA, and FA for primary PCI in patients with STEMI. The principal
findings were as follows: (1) The success rate of DRA was 83.3% (35/42), including five
cases of failed puncture and two cases of failed sheath cannulation. (2) Primary PCI was
successful in all 35 patients with successful DRA. (3) Rates of access-site complications
for DRA were low and comparable to those for PRA and FA, and no major bleeding
complications were observed in the DRA group.
Several studies have reported that the success rates of DRA for coronary angiography
(CAG) or PCI range from 88.0–95.5% [9–11]. A recent study further reported a DRA
success rate of 92.8% in patients with STEMI [14]. However, the success rate of DRA for
primary PCI was relatively lower in our study at 83.3% (35/42). Detailed information
for the patients in whom DRA failure was observed is summarized in Supplementary
Table S3. The lower success rate in the present study may be explained by our inclusion of
three inexperienced DRA operators who may need to overcome a learning curve for DRA.
Recently, we reported that 200 cases would be needed to overcome the learning curve with
a consistently high success rate (>94.0%), and that female sex and systolic blood pressure
(SBP) <120 mm Hg are predictors of failed DRA [18]. Therefore, DRA should be considered
in select patients with STEMI (male patients and those with high SBP) undergoing primary
PCI when the operator has utilized DRA in over 200 cases of CAG or PCI.
In the current study, the proportion of puncture time in D2WT was also comparable
among the DRA, PRA, and FA groups when crossover cases were excluded. In addition,
the proportion of puncture time within 3 and 5 min was very high for DRA (88.6% [31/35]
and 100% [35/35] patients, respectively). Previous studies have reported puncture times
of 1.19 to 3.9 min for DRA [11,14,19,20]. Thus, the puncture time of DRA in patients with
STEMI in the current study is acceptable when compared with puncture times for other
vascular access routes.
There has been some concern regarding the possibility of delays in puncture time, which
may result in a delay in D2WT in patients presenting with STEMI because the distal radial
artery is smaller than the proximal radial artery or femoral artery [10]. Although puncture
time was longer for DRA than for PRA among patients with successful vascular access, our
analysis of real-world data indicated that this difference was not statistically significant and
did not lead to a delay in D2WT. In contrast, among patients with initial puncture failure
requiring conversion to another site, we observed significant increases in puncture time and
the proportion of puncture time to D2WT. Therefore, as suggested in our previous study,
operators should remain aware that delayed puncture over 5 min can be considered an
indication of the need to change the puncture site for the safety of patients [14].
In the present study, successful primary PCI was achieved in all 35 DRA cases, and
left DRA was performed in 34 (97.1%) patients in DRA group. Although right PRA is
often used for operator comfort, it has the disadvantage of potential anatomic variations
and poor back-up force due to the S-shaped geometry of the subclavian–innominate–aorta
axis [21]. Furthermore, the risk of embolic stroke is increased because the catheter needs
to be passed from the innominate artery into the ascending aorta where the right carotid
artery comes off [22]. In contrast, the left PRA is advantageous due to the ease with which
the catheter can be manipulated (similar to FA); however, physical discomfort remains
a barrier for some operators. The left DRA can overcome this barrier, as the patient’s
elbow is slightly bent, and the left hand is positioned above the left groin. In addition to
these strengths, a previous study reported a 100% success rate of PCI via the left DRA for
bifurcation lesions without crossover [12]. Further large-scale randomized trials should
be conducted to compare the feasibility of left and right DRA for complex PCI including
primary PCI in patients with STEMI.
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Previous studies have reported no major complications (including major bleeding)
in patients undergoing CAG or PCI via the DRA [9–12,14,20,23,24]. In the present study,
we observed no major bleeding in the DRA group, for which rates of P2Y12 inhibitor
and glycoprotein IIb/IIIa inhibitor use were 83% and 26%, respectively. Local hematoma
<5 cm in diameter was observed in only two patients, although both fully recovered within
1 month. In contrast, major bleeding requiring transfusion and surgical treatment due to
access-site vascular injury occurred in patients with FA. Therefore, DRA may represent
an alternative access route in patients with a high risk of bleeding and in those in whom
bleeding complications must be minimized.
This study had some limitations. First, the study was a retrospective, observational
study—a design associated with inherent selection and information bias. Second, the small
number of patients included in the study limits its statistical power. Third, puncture failure
may still be a barrier to the success of DRA. Further study is needed on whether ultrasound-
guided puncture can reduce puncture failure. Fourth, since ultrasound guidance was
used in all cases of FA, this may have resulted in research bias, especially with regard to
puncture time. Fifth, the lack of routine postprocedural ultrasonography for the puncture
site may have contributed to underestimation of puncture-site complications. Despite these
limitations, our findings are expected to aid interventional cardiologists in understanding
the feasibility of DRA for primary PCI in the setting of STEMI.
5. Conclusions
Despite the relatively low success rate of DRA in patients with STEMI, the success
rate of primary PCI was 100% in cases of successful DRA. Moreover, there were no major
access-site complications in patients with successful DRA, and puncture time and the
proportion of puncture time in the D2WT were comparable to those for PRA and FA. For
highly experienced operators who have overcome the learning curve, primary PCI via the
DRA (especially on the left side) may represent a feasible alternative in select patients with
STEMI, such as those with a high risk of bleeding.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/jcm10153438/s1, Table S1: Baseline characteristics; Table S2: Angiographic and procedural
characteristics; Table S3: Characteristics of patients with failed DRA.
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